Safety and Immunogenicity Study of Revaccination With SCB-1019T in Healthy Adults
Safety and Immunogenicity Study of Revaccination With SCB-1019T in Healthy Adults
Recruiting · NCT06843317 · Registry updated 2025-05-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Immunogenicity Study of Revaccination With SCB-1019T in Healthy Adults | Infections, Mononegavirales infectious disease, Paramyxoviridae infectious disease, Pneumovirus Infections, RNA Virus Infections, respiratory syncytial virus infectious disease, viral infectious disease | Recruiting | Phase 1 | 2025-05-14 | NCT06843317 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Clover Biopharmaceuticals USA, LLC | 1 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| AMR Fort Myers | Fort Myers | United States | 2 |
| AMR Kansas City | Kansas City | United States | 6 |
| AMR Lexington | Lexington | United States | 8 |
| AMR Phoenix | Phoenix | United States | 1 |
| Knoxville | Knoxville | United States | 1 |